Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Brandner

Showing results (311-320 of 369) with videos related to

Pageof 37
Sort By:
Nature Medicine|July 18, 2018
Fetal gene therapy for neurodegenerative disease of infantsGiulia Massaro, Citra N Z Mattar, Andrew M S Wong, et al.
Acta Neuropathologica|June 20, 2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entitiesDavid E Reuss, Annekathrin Kratz, Felix Sahm, et al.
Journal of Neuropathology and Experimental Neurology|October 1, 2020
Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and UnknownsDavid M Asher, Ermias Belay, Eileen Bigio, et al.
Brain : a Journal of Neurology|October 13, 2022
The genomic landscape across 474 surgically accessible epileptogenic human brain lesionsJavier A López-Rivera, Costin Leu, Marie Macnee, et al.
Brain : a Journal of Neurology|May 25, 2016
Genetic and phenotypic characterization of complex hereditary spastic paraplegiaEleanna Kara, Arianna Tucci, Claudia Manzoni, et al.
Brain : a Journal of Neurology|April 13, 2026
Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypesPatrick W Cullinane, Jacy Bezerra Parmera, Hemanth Nelvagal, et al.
Acta Neuropathologica|July 18, 2024
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterationsPhilipp Sievers, Franck Bielle, Kirsten Göbel, et al.
Human Molecular Genetics|December 4, 2014
A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicityPeter I Joyce, Philip Mcgoldrick, Rachele A Saccon, et al.
Neuro-Oncology|November 22, 2024
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selectionFelix Sahm, Luca Bertero, Sebastian Brandner, et al.
Scientific Reports|October 29, 2017
Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease miceMarie K Bondulich, Nelly Jolinon, Georgina F Osborne, et al.
Pageof 37

Showing results (311-320 of 369) with videos related to

Sort By:
Pageof 37
Nature Medicine|July 18, 2018
Fetal gene therapy for neurodegenerative disease of infantsGiulia Massaro, Citra N Z Mattar, Andrew M S Wong, et al.
Acta Neuropathologica|June 20, 2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entitiesDavid E Reuss, Annekathrin Kratz, Felix Sahm, et al.
Journal of Neuropathology and Experimental Neurology|October 1, 2020
Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and UnknownsDavid M Asher, Ermias Belay, Eileen Bigio, et al.
Brain : a Journal of Neurology|October 13, 2022
The genomic landscape across 474 surgically accessible epileptogenic human brain lesionsJavier A López-Rivera, Costin Leu, Marie Macnee, et al.
Brain : a Journal of Neurology|May 25, 2016
Genetic and phenotypic characterization of complex hereditary spastic paraplegiaEleanna Kara, Arianna Tucci, Claudia Manzoni, et al.
Brain : a Journal of Neurology|April 13, 2026
Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypesPatrick W Cullinane, Jacy Bezerra Parmera, Hemanth Nelvagal, et al.
Acta Neuropathologica|July 18, 2024
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterationsPhilipp Sievers, Franck Bielle, Kirsten Göbel, et al.
Human Molecular Genetics|December 4, 2014
A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicityPeter I Joyce, Philip Mcgoldrick, Rachele A Saccon, et al.
Neuro-Oncology|November 22, 2024
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selectionFelix Sahm, Luca Bertero, Sebastian Brandner, et al.
Scientific Reports|October 29, 2017
Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease miceMarie K Bondulich, Nelly Jolinon, Georgina F Osborne, et al.
Pageof 37